Amgen Inc. Long-Term Debt
Amgen Inc. (AMGN) had Long-Term Debt of $51.86 billion as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LongTermDebtNoncurrent · last filed 2026-08-05
- 2026-06-30: Long-term Debt, Excluding Current Maturities $51.86B.
- 2026-03-31: Long-term Debt, Excluding Current Maturities $51.89B.
- 2025-12-31: Long-term Debt, Excluding Current Maturities $50.01B.
- 2025-09-30: Long-term Debt, Excluding Current Maturities $52.43B.
| Period end | Long-term Debt, Excluding Current Maturities | Long-term Debt, Excluding Current Maturities as first filed |
|---|---|---|
| 2026-06-30 | $51.86B 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $51.89B 10-Q · filed 2026-05-01 | |
| 2025-12-31 | $50.01B 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $52.43B 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $53.76B 10-Q · filed 2025-08-06 | |
| 2025-03-31 | $54.01B 10-Q · filed 2025-05-02 | |
| 2024-12-31 | $56.55B 10-K · filed 2026-02-13 | |
| 2024-09-30 | $56.85B 10-Q · filed 2024-10-31 | |
| 2024-06-30 | $57.12B 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $60.06B 10-Q · filed 2024-05-03 | |
| 2023-12-31 | $63.17B 10-K · filed 2025-02-14 | |
| 2023-09-30 | $59.04B 10-Q · filed 2023-10-31 | |
| 2023-06-30 | $59.38B 10-Q · filed 2023-08-04 | |
| 2023-03-31 | $60.76B 10-Q · filed 2023-04-28 | |
| 2022-12-31 | $37.35B 10-K · filed 2024-02-14 | |
| 2022-09-30 | $37.16B 10-Q · filed 2022-11-04 | |
| 2022-06-30 | $35.70B 10-Q · filed 2022-08-05 | |
| 2022-03-31 | $36.01B 10-Q · filed 2022-04-28 | |
| 2021-12-31 | $33.22B 10-K · filed 2023-02-09 | |
| 2021-09-30 | $33.29B 10-Q · filed 2021-11-03 | |
| 2021-06-30 | $28.46B 10-Q · filed 2021-08-04 | |
| 2021-03-31 | $31.13B 10-Q · filed 2021-04-28 | |
| 2020-12-31 | $32.90B 10-K · filed 2022-02-16 | |
| 2020-09-30 | $34.20B 10-Q · filed 2020-10-29 | |
| 2020-06-30 | $34.13B 10-Q · filed 2020-07-29 | |
| 2020-03-31 | $30.01B 10-Q · filed 2020-05-01 | |
| 2019-12-31 | $26.95B 10-K · filed 2021-02-09 | |
| 2019-09-30 | $27.74B 10-Q · filed 2019-10-30 | |
| 2019-06-30 | $27.80B 10-Q · filed 2019-07-31 | |
| 2019-03-31 | $29.32B 10-Q · filed 2019-05-01 | |
| 2018-12-31 | $29.51B 10-K · filed 2020-02-12 | |
| 2018-09-30 | $29.35B 10-Q · filed 2018-10-31 | |
| 2018-06-30 | $30.21B 10-Q · filed 2018-07-27 | |
| 2018-03-31 | $33.36B 10-Q · filed 2018-04-25 | |
| 2017-12-31 | $34.19B 10-K · filed 2019-02-13 | |
| 2017-09-30 | $33.78B 10-Q · filed 2017-10-26 | |
| 2017-06-30 | $33.60B 10-Q · filed 2017-07-26 | |
| 2017-03-31 | $30.29B 10-Q · filed 2017-04-27 | |
| 2016-12-31 | $30.19B 10-K · filed 2018-02-13 | |
| 2016-09-30 | $30.53B 10-Q · filed 2016-10-28 | |
| 2016-06-30 | $27.93B 10-Q · filed 2016-07-29 | |
| 2016-03-31 | $32.06B 10-Q · filed 2016-05-02 | |
| 2015-12-31 | $29.18B 10-K · filed 2017-02-14 | $29.31B 10-K · filed 2016-02-16 |
| 2015-09-30 | $30.51B 10-Q · filed 2015-11-02 | |
| 2015-06-30 | $30.70B 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $29.84B 10-Q · filed 2015-04-27 | |
| 2014-12-31 | $30.09B 8-K · filed 2016-10-31 | $30.21B 10-K · filed 2015-02-19 |
| 2014-09-30 | $30.48B 10-Q · filed 2014-10-29 | |
| 2014-06-30 | $30.83B 10-Q · filed 2014-08-05 | |
| 2013-12-31 | $29.62B 10-K · filed 2015-02-19 | |
| 2011-06-30 | $13.85B 10-Q · filed 2011-08-08 | |
| 2011-03-31 | $10.82B 10-Q · filed 2011-05-10 | |
| 2010-12-31 | $10.87B 10-Q · filed 2011-08-08 | |
| 2010-09-30 | $10.84B 10-Q · filed 2010-11-08 | |
| 2010-06-30 | $9.32B 10-Q · filed 2010-08-09 | |
| 2009-12-31 | $10.60B 10-K · filed 2011-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GILEAD SCIENCES, INC. (GILD) | United States | $185.522B | -48.37 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |